Knee Osteoarthritis Clinical Trial
Official title:
Pilot, Prospective, Comparative Multicentric Study Evaluating the Effects on the Arthrosis Biomarkers, the Clinical Effectiveness, the Tolerance of an Intra-articular Injection of Hyaluronic Acid KARTILAGE CROSS Versus Placebo in Patients Suffering From Knee Osteoarthritis.
Intra-articular hyaluronic acid injections, also known as viscosupplementation, are a
treatment option for knee osteoarthritis that serves to restore the decreasing rheological
properties of synovial fluid. KARTILAGE® CROSS is a visco-elastic gel of highly purified
reticulated hyaluronic acid. It contains mannitol to provide an anti-oxidative action and to
avoid hyaluronic acid depolymerization. Reticulation and mannitol increase the residency
time of the product in the joint cavity then allowing a single injection in painful knee
osteoarthritis patients.
The US food and drugs administration (FDA) and European medicine agency (EMA), have recently
published guidelines recommending a higher level of integration of biomarkers in the
development and testing of new drugs to advance decision-making on dosing, time and
treatment effect, trial design, and risk/benefit analysis. Biomarkers can be used not only
in the process of drug development, but also in the future in assessment of individual
patient's response to treatment.
Several soluble biomarkers have been identified as potential candidates to predict or
monitor the efficacy of intervention. Coll2-1, a degradation product of type II collagen,
and Coll2-1NO2, a nitrated form of the Coll2-1 peptide have been studied in human
osteoarthritis and entered the qualification process. Evidences demonstrated them to be
pertinent and to be foresee as markers used for the diagnosis, the prognosis, the burden of
disease and the monitoring of a treatment efficacy.
The aim of this study was to provide with the first kinetic data regarding biomarkers in
painful knee osteoarthritis patients treated with a new reticulated hyaluronic acid. The
effects of the treatment were compared to those of saline solution. The primary endpoint was
a specific osteoarthritis biomarker, Coll2-1. The secondary endpoints were the effects of
the treatment or placebo on other biomarkers of osteoarthritis, its clinical efficacy and
tolerance
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04651673 -
Prescribed Knee Brace Treatments for Osteoarthritis of the Knee (Knee OA)
|
||
Completed |
NCT05677399 -
Knee Osteoarthritis Treatment With Peloidotherapy and Aquatic Exercise.
|
N/A | |
Active, not recruiting |
NCT04043819 -
Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis
|
Phase 1 | |
Recruiting |
NCT06000410 -
A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee
|
Phase 3 | |
Completed |
NCT05014542 -
Needling Techniques for Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT05892133 -
Prehabilitation Effect on Function and Patient Satisfaction Following Total Knee Arthroplasty
|
N/A | |
Recruiting |
NCT05528965 -
Parallel Versus Perpendicular Technique for Genicular Radiofrequency
|
N/A | |
Active, not recruiting |
NCT03472300 -
Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
|
||
Active, not recruiting |
NCT02003976 -
A Randomized Trial Comparing High Tibial Osteotomy Plus Non-Surgical Treatment and Non-Surgical Treatment Alone
|
N/A | |
Active, not recruiting |
NCT04017533 -
Stability of Uncemented Medially Stabilized TKA
|
N/A | |
Completed |
NCT04779164 -
The Relation Between Abdominal Obesity, Type 2 Diabetes Mellitus and Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT04006314 -
Platelet Rich Plasma and Neural Prolotherapy Injections in Treating Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT05423587 -
Genicular Artery Embolisation for Knee Osteoarthritis II
|
N/A | |
Enrolling by invitation |
NCT04145401 -
Post Market Clinical Follow-Up Study- EVOLUTION® Revision CCK
|
||
Active, not recruiting |
NCT03781843 -
Effects of Genicular Nerve Block in Knee Osteoarthritis
|
N/A | |
Completed |
NCT05974501 -
Pre vs Post Block in Total Knee Arthroplasty (TKA)
|
Phase 4 | |
Completed |
NCT05324163 -
Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis
|
Phase 3 | |
Completed |
NCT05529914 -
Effects of Myofascial Release and Neuromuscular Training for Pes Anserine Syndrome Associated With Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT05693493 -
Can Proprioceptive Knee Brace Improve Functional Outcome Following TKA?
|
N/A | |
Not yet recruiting |
NCT05510648 -
Evaluation of the Effect of High-intensity Laser Therapy in Knee Osteoarthritis
|
N/A |